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 Abstract: Obesity results from a long-term positive energy balance, in which gene-
related differences may account for some of the disparities found in weight gain among 
populations. However, the rising prevalence of obesity in developed and developing 
societies must reflect lifestyle changes. Despite that the genetic background remains 
stable over many generations, obesity may be derived from a failure on the homeostasis 
systems, as a consequence of a dysfunction at the genetic level, which may be affected 
by changing environmental exposure (dietary habits, sedentarism, etc). In practice, 
obesity risk at least depends on two important factors, which mutually interact: 1) 
genetic variants and gene expression changes in candidate genes and 2) exposure to 
environmental risk factors.  
Disagreements among studies involving gene-nutrient interactions may reflect the 
difficulty of accurate measurement of specific types of dietary macro and micronutrients 
as well of phenotype assessment rather than a discrepancy in biological relevance. 
Identification of individuals who are genetically more likely to respond to particular 
dietary changes may be important for successful intervention in obesity treatment, since 
gene screening will allow health professionals to tailor-design weight management and 
dietary guidance in individuals with a genetic predisposition to become obese. 
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Dietary and genetic evolution 
 
The diversity in dietary habits as well as on genetics traits among human beings has 
been enormous during the evolutive period of the mankind [1]. There are records of the 
various diets followed by different populations world-wide. Data from the Stone Age 
(35000-10000 BC) suggest a low fat intake (<22 as en%) and a high protein and 
carbohydrate consumption (about 40 as en%). The hunters-gatherers lifestyle, which 
influences the animal or plant food availability sustained humanity for the subsequent 
10,000 years, and markedly affected the macronutrient intake (protein 19-35 as en%), 
carbohydrate 22-40 as en%, fat 28-58 as en%. With advances in agriculture and 
livestock breeding (10 000 BC to third millennium), the achieved values during the last 
century were 10-17 as en% for protein, 40-60 as en% for carbohydrate and 20-59 as 
en% for fat. In most industrialised countries more fat (40-50 en%), especially saturated 
fats and less carbohydrates (40-45% E) were eaten, which was associated to a relevant 
reduction of starch consumption. Besides, individuals in high and low income countries 
have experienced important and rapid changes with regard to diet in the last decades, 
accompanied by a growing prevalence of chronic diseases, including obesity. 
However, since the time when man appeared on earth (about 2.4x106 years), only minor 
changes have occurred in the human genome [2]. In fact, a difference in the gene make 
up of only about 1.6 % was found between modern man and most developed primates. 
In spite of this overall stability of the human genome, a number of minor alterations in 
gene structures have been observed. Thus, ethnic and racial differences for various traits 
have long been recognised. Also, some specific genes have been reported recently to be 
in connection with the risk of developing obesity, type 2 diabetes or cardiovascular 
disease. For obese individuals, numerous single polymorphisms have been discovered 
and characterised in the last two decades [2, 3]. 
 
Genetic and dietary influences on obesity at the present time 
 
Obesity as a complex disease associated to an excessive fat deposition, rarely arise from 
a unique mutation in a single gene, although there is one relevant example. Monogenic 
obesity is caused by single mutations in the melanocortin 4 receptor (MC4R) which 
participates in food intake regulation [4, 5]. There are more than 40 functionally 
relevant MC4R mutations in 2-4% of extremely obese individuals.  
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Commonly, an obese individual will have inherited minor functional mutations or gene 
variants in genes coding for key proteins involved in the regulation of body weight 
[6,7]. These combined genetic effects account for the biological diversity and in their 
absence all organisms would respond in a virtually identical manner to the same 
environmental challenge. Thus, the interaction of functional gene polymorphisms with 
environmental factors may play a substantial role in the risk of developing obesity. 
The research of gene-environment interactions implies that the interplay between 
genotype and environment deviates from the additive or multiplicative effects of these 
two factors (Figure 1). This outcome could be a result of chance alone, which highlights 
the importance of confirmatory findings, but an absence of interaction, could also 
simply reflect the lack of statistical power (i.e. sample size) in the study to detect such 
an effect [8]. Genotype-environment interactions (G x E) arise when the response of a 
phenotype (e.g., body weight) to environmental changes (e.g., overfeeding) depends on 
the individuals genetic background. Most of the genetic epidemiology studies on human 
obesity have assumed the absence of genotype-environment interactions simply because 
of the difficulties in assessing such interactive effects in quantitative genetic models. 
A working model for the interaction of genetic and environmental factors is presented 
(Figure 2). A higher obesity risk (represented by a quantitative trait BMI) will arise 
from the presence of an obesity-related gene variant and environmental influences (high 
consumption of carbohydrates) for a population carrying a given polymorphism. Indeed, 
individuals inherited a number of gene variants in key loci, but they make some 
particular lifestyle choices (e.g. low-fat versus high-fat diets, high versus low levels of 
physical activity, etc.) affecting weight gain. Thus, while environmental factors may be 
changed in the short-term, genetic factors can not, but they might interplay. The gene-
environment relationship is a big challenge to be faced for scientist.  
 
Measuring genetic and environmental factors 
 
There are several well-documented environmental variables that influenced body weight 
gain and increased obesity risk [9-16]. These variables include excessive calorie intake 
and sedentary lifestyles. However, these environmental variables are often difficult to 
quantify with accuracy in free-living individuals. In small intervention studies, it is 
possible to estimate energy intake and expenditure with a high degree of accuracy, but 
such experimental trials usually have very little power for genetic studies or for 
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screening gene-environmental interactions. Besides, there is large inter-individual 
diversity in metabolic responses. Generally in intervention studies over 50% of the 
subjects show changes in the main direction, a minority of subjects does not exhibit any 
change, and a few subjects show changes in the opposite direction. This observation 
clearly indicated that each subject can display both general traits and some particular 
susceptibility to a given environment (dietary) factor [8].  
Moreover, most environmental factors are assessed by questionnaires and may be 
under-reported (e.g. food intake) or over-reported in the case of exercise. In regard to 
food intake, daily food records may be useful, but assessing fat content or fatty acid 
composition is not straightforward [8]. What is desirable is to have biological markers 
for environmental factors, like plasma measures of by-products that can be objectively 
quantified as a marker of dietary compliance. 
 
Environmental risk factors: Diet composition 
The content and distribution of the macronutrient intake appears to strongly influence 
the regulation of food intake and may affect energy utilisation [13, 15]. The ratio fat to 
carbohydrate is the main factor that easily causes passive energy overconsumption 
leading to weight gain [16]. The combination of carbohydrate-sweetened beverages 
intake and an increasingly sedentary lifestyle, which reduces the metabolic demand for 
fat as fuel, has been associated to an excessive weight gain. Long-term studies are 
needed to explore the independent effects of dietary sugars (solid or liquid) and 
glycemic load on body weight control.  
There are more epidemiological data associating high-fat consumption with obesity 
development, although the results appear to be indicative but no conclusive. A 
controversial question is whether or not high-fat diets versus low-fat diets with the same 
equivalent total energy contributed to weight gain [10, 11]. In several weight-loss 
studies prescribing low carbohydrate diets (moderate to high fat content) as compared to 
low fat diets, there was no major difference in the average weight reduction [17]. In 
another trials, a more beneficial lipid profile was found in individuals fed on high fat 
diet [18]. This heterogeneity supports the idea that there are individual differences in the 
fat responses, which maybe partially explained by genetic susceptibility and gene-
nutrient interactions. 
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Genetic risk factors 
Despite that dietary factors play a significant role in the development of obesity, a 
number of reports over the last decades have clearly documented a genetic contribution 
to obesity-related phenotypes as well [2-5]. Obesity and its related traits represent the 
archetype of a common complex phenotype. The configuration of multiple genes can 
range from polygenic (i.e. many genes with a relatively small contribution) to 
oligogenic (i.e. few genes with large measurable effects often expressed on a residual 
polygenic background). Indeed, it is this oligogenic architecture that warrants all current 
efforts to map genes for complex phenotypes [19, 20].  
In this context, quantitative genetic analyses (twins, siblings and family studies) have 
shown significant hereditability (an individual’s chances of being obese are increased 
when having obese relatives) with estimates generally ranging from 30-70% [4, 6].  
From the late 1980s through the early 1990, segregation analysis was applied in an 
effort to dissect further the genetic architecture underlying human obesity by attempting 
to detect the effects of anonymous major genes on obesity related phenotypes. A 
number of these studies have reported consistent evidence of anonymous major gene 
effects accounting for as much as 40% of the variation in BMI or fat mass in a variety of 
populations [6, 20].  
By the early to mid-1990s, researchers began to focus on the goal of identifying the 
specific genes involved. Initially such effort to identify specific genes influencing 
complex traits such as those associated with obesity relied on the use of a priori defined 
candidates genes [3, 19]. Such candidate genes are selected on the basis of their 
perceived role or function in biochemical pathways relevant to the specific phenotype of 
interest (e.g. the structural gene for a circulating protein). The conservation of 
hypothalamic pathways in rodents and humans has certainly helped in choosing suitable 
candidates genes. All the spontaneously occurring obesity mutations in mice either have 
been found to harbour functionally relevant mutations in humans too, or have led to the 
identification of a system/pathway, in which other genes were found to be mutated. The 
molecular genetic biology tools recently developed allow the determination of most 
gene polymorphism from a blood sample, especially single nucleotide polymorphism 
(SNP). This advance opens a new era, where studies devoted to interaction between 
diets, metabolic variables, disease risk factors, and gene polymorphism can be 
conducted. According to the latest version of the Gene Obesity Map 2003 there are 
more than 430 genes, markers and chromosomal regions involved in body weight 
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regulation and obesity development [2]. Moreover, there are 272 studies in obese 
humans reporting positive associations with 90 candidate genes [2, 3]. Here a selective 
number of mutations in genes encoding factors regulating food/energy intake as well as 
factors related to energy expenditure and adipogenesis is reviewed. 
 
Genetic background and obesity 
 
Body weight regulation and stability depends upon an axis with three interrelated 
components: food intake, energy expenditure and adipogenesis, although there are still 
many unknown features concerning fuel homeostasis and energy balance, in which the 
genetic make-up is involved. 
 
Genes encoding factors regulating food/energy intake 
Hypothalamic and brain stem centres are involved in the regulation of food intake and 
energy balance, but information on the relevant regulatory factors was scarce before the 
last decade [3, 19]. Insulin remained the only candidate with a  key role in body weight 
regulation for a long time until the discovery of leptin. This cytokine-like peptide 
mainly expressed by adipocytes is now believed to be a key regulator of fat metabolism 
and energy intake. Leptin is the product of human homologue of mouse “obese” gene, 
whose homozygous mutation caused hereditary obesity in mice (monogenic) [20-22]. 
The mechanisms participating in the effects of leptin and other peptides on food intake 
and body weight regulation are now becoming to be understood. Factors acting at the 
central nervous system level include: neuropeptide Y, corticotropin releasing hormone, 
proopiomelanocortin, α-melanocyte stimulating hormone, agouti-related protein, 
melanin-concentrating hormone, cocaine-and amphetamine regulated transcript and 
other molecules [3, 20]. Interactions among them involving complex neuronal 
mechanisms, eventually influence behavior and provide important links with 
neuroendocrine regulation of other vital functions of the organism.  
Studies in humans have failed to find leptin or any other mutant gene to be the unique 
“obesity gene”. Conversely, multifactorial patterns involving the action of numerous 
polymorphic gene products now look more likely to occur. Evidence is accumulating 
that most of these genes encoding central peptide factors as well as their receptors 
(leptin receptors, melanocortin receptors, NPY receptors) are polymorphic [19].  
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Dominant inheritance of obesity conferred by missense, nonsense and frameshift 
mutations in the melanocortin 4 receptor gene (MC4R) has been extensively reported in 
many populations including French, English, German, American and Italian individuals 
[3-4,21-22]. It has been estimated that 4-6% of extremely obese individuals harbor 
functionally relevant MC4R mutations. Mutations of the MC4R, two nonsense (Tyr-35-
Stop, Trp-16-Stop) and several frameshift mutations (732-733insGATT, 631-
634delCTCT, 47-48insG) can be considered loss-of-function mutations and are 
associated with dominant inheritance of obesity [21-22]. However, other mutations (i.e.: 
Thr-11-Ser, Arg-18-Cys) and polymorphisms (Val-103-Ile, Ile-251-Leu) did not modify 
the function of the MC4R in vitro.  
NPY is released from the arcuate hypothalamic nucleus in fasting or hypoglycemia 
situations and its secretion is inhibited after food intake. The Leu7Pro polymorphism in 
the NPY gene appears to be involved in lipid metabolism regulation. It is highly 
prevalent in Caucasians, but not in Japaneses and this suggests that the role of this 
polymorphism may vary across different population groups. Common polymorphisms 
in the genes encoding NPY receptors can present another source of variation in this 
appetite signalling system [19].  
A number of peptides synthesised along the gastrointestinal tract also affect food intake. 
They include ghrelin (orexigenic peptide mainly produced in the stomach), 
cholecystokinin (produced in the small intestine acting as a short-term satiety signal) 
and peptide YY3-36 (produced in the colon and suppressing appetite for up to 12 hour). 
Exploration of these signalling pathways has started and it is becoming clear that 
polymorphisms in relevant genes may have important functional consequences. One 
SNP in the highly polymorphic ghrelin gene was found to be associated with fat 
accumulation [19].  
Moreover, the identification of relevant genes related to food preferences has just 
started. Taste 2 receptors (T2Rs) have been shown to function as bitter taste receptor 
and T1Rs as putative receptor for sweet taste. There is no information on polymorphism 
in the T1R family genes, while some SNPs in T2R have been reported [19]. Rapid 
progress has been made in this field to elucidate the genetic mechanism underlying food 
preferences.  
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Genes encoding factors involved in energy expenditure 
The adaptive thermogenesis in humans is closely related to the active mobilisation of 
lipids from fat tissues and presents special interest in relation to obesity. Central neural 
pathways responsible for the food intake and energy expenditure regulation are tightly 
interconnected. The peripheral transmission of central commands to the fat stores is 
mediated by sympathetic nervous system. The β-adrenoceptor gene family contains 
classical obesity candidate genes for its role in the regulation of energy expenditure [3, 
23-32].  
The β2-adrenergic receptor gene (ADRB2) encodes a major lipolytic receptor protein in 
human fat cells. Two common polymorphism of the ADRB2 gene, characterised by an 
amino acid replacement of arginine by glycine in codon 16 (Arg16Gly) and glutamine 
by glutamic acid in codon 27 (Gln27Glu) have been explored in diseases such as 
hypertension and obesity. A relationship between the Arg16Gly polymorphism and an 
altered function of the ADBR2 has been reported leading to a decreased agonist 
sensitivity. There is some evidence that the Gln27Glu polymorphism of the ADRB2 
may alter lipolytic function contributing to fat accumulation. In men, the 27Glu allele 
has been associated with increased BMI, subcutaneous fat, elevated leptin and 
triglycerides levels and increased risk for abdominal obesity [27]. In an intervention 
study, our group has shown that women homozygotes for the 27Glu allele have 
impaired the exercise-stimulated lipolysis [23-24]. We also observed an effect 
modification (interaction) on obesity risk linked to the 27Glu polymorphism by 
recreational energy expenditure levels. Women carrying of the 27Glu allele and active 
in their leisure time had a higher BMI compared to non-carriers, being more resistant to 
lose weight when they were exposed to higher physical activity levels [30].  
The β3-adrenergic receptor (ADRB3) protein plays a role in adipocyte metabolism 
mediating the rate of lipolysis in response to catecholamines. A common polymorphism 
in this gene, characterised by an amino acid replacement of tryptophan by arginine at 
position 64 (Trp64Arg), has been identified and may be linked to lower lipolytic 
activity accounting for lipid accumulation in adipose tissue [3, 19]. In regard to BMI, 
more than nine studies had shown a statistically significant association between BMI 
and the Trp64Arg polymorphism in a variety of populations. Moreover, 2 meta-analysis 
examining the effect of this mutation on BMI have been published for Caucasian 
populations [3, 26]. One includes 2.447 subjects and the significant BMI difference 
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among carriers and non-carriers of the mutation is 0.30 kg/m2. In the second survey on 
7399 subjects, the results were not statistically significant.  
Clement et al [32] found that morbidly obese subjects with the Arg allele in the ADRB3 
gene had a significantly higher weight gain (current weight –weight at 20 years). 
Similarly, several studies carried out among Mexican American, Japanese and 
Caucasian women have showed that carriers of the Arg allele had a higher BMI and 
lower reduction in visceral fat after weight-loss [3]. In a Spanish population we found 
an age-dependent effect for obesity risk linked to the Try64Arg variant. Carriers of the 
Arg 64 allele younger than 33 years-old have a significant higher risk of developing 
obesity. Some authors, however, failed to reproduce the finding in regard to β-
adrenoceptors and further confirmation is required. It is possible that the study of 
lifestyle influences and other circumstances may unmask the effects of a given gene 
variant.   
Whereas β-adrenoceptors participate in the regulation of adaptive thermogenesis as a 
component of sympathetic responses, the ultimate control and modulation of heat-
generating uncoupled respiration at the mitochondrial level is apparently exerted by 
uncoupling proteins (UCPs). They represent a family of carrier proteins located in the 
inner layer of mitochondrial membranes [19]. There are different members. UCP 1 
mostly expressed in brown adipose tissue with a role in thermogenesis. UCP2 
ubiquitously present in many tissues and UCP3 mainly expressed in skeletal muscle and 
brown adipose tissue. Their putative function as “uncoupling proteins” have been 
intensively explored [33-34], but their role is still under investigation. Thus, UCP2 and 
UCP3 appear to be regulators of energy homeostasis, acting as a fatty acid 
transmembrane transporter in the mitochondria and facilitating protons exchange [3]. 
These observations have led to the consideration of UCP´s as candidate genes for 
obesity, given their function in the regulation of fuel metabolism. 
A number of human studies indicated a relationship between UCP´s polymorphisms and 
exercise efficiency, resting energy expenditure, substrate oxidation, energy metabolism, 
BMI, leptin, fat accumulation, body weight changes, physical activity and also risk of 
type 2 diabetes or obesity [33-34]. Several UCP2 gene variants were described: a G/A 
mutation in the promoter region –866G/A, a valine for alanine substitution at amino 
acid 55 in exon 4 (Ala55Val) and a 45 base pair insertion/deletion in the untranslated 
region of exon 8 [34]. The association between these polymorphisms of the UCP2 and 
various aspects of obesity has been intensively studied. It seems that the allele G in the 
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promoter region of UCP2 increases obesity risk, while it affords relative protection for 
type 2 diabetes [3]. Meanwhile the Ala55Val polymorphism has shown to be associated 
with increased exercise efficiency [3]. However, results concerning the exon 8 insertion 
allele of the UCP2 gene have been inconsistent. Although no association with obesity 
was observed in a number of studies conducted in several populations [33], significant 
associations between the exon 8 insertion of the UCP2 gene and BMI or fat mass or 
presence of obesity were found. Thus, in a Spanish sample we also reported a higher 
obesity risk for carriers of the exon 8 insertion allele of the UCP2 gene after adjusting 
for lifestyle influences [34].  
There are also several UCP3 gene variants potentially involved in weight gain 
regulation. In linkage studies, some of them have been related to a higher obesity risk 
[3]. Specifically, the -55CÆT polymorphism in the promoter region, which has been 
associated with an elevated body mass index (BMI), an increased level of adiposity or a 
greater waist-to-hip ratio [3]. However, other authors have not found any relationship 
between this polymorphism and a higher risk of obesity or changes in metabolic rate. 
Some studies have even reported an inverse correlation with BMI and the presence of –
55CÆT polymorphism [3]. The inconsistencies in some studies may be due to 
differences in the populations studied, methodological issues and the lack of an 
adequate consideration of confounding factors (age, gender and lifestyle factors) 
affecting gene x nutrient interactions.  
 
Genes encoding factors involved in adipocyte metabolism 
The last group of genes acting in connection with the peripheral regulation of energy 
expenditure encompasses the transcription factors leading to adipogenesis and adipocyte 
differentiation. The key actors are peroxisome proliferator-activated receptor γ, 
particularly the adipose specific isoform PPARG2. In a meta-analysis with 19,136 
subjects, a positive association between BMI and the Pro12Ala polymorphism of the 
PPARG2 gene was found [35]. In a Spanish group, the frequency of the Ala allele was 
similar to other Caucasian populations, but higher in obese subjects (allelic frequency 
0.13) compared to controls (0.08) suggesting that this polymorphism was associated 
with obesity [36]. There is also information on the functional role of PPARG gene 
variants and some mutants proteins appear to have a reduced activity [3]. 
Discrepancies among investigators on the effect of a given polymorphism on obesity-
phenotypes may be explained by the environmental influences. The lifestyle factors 
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specially those related to diet (macronutrient composition or total energy intake) can 
interact with the genetics factor and may mask the genotype influences.  
   
Strategies for searching gene-diet interactions in regard to obesity phenotypes 
 
It is possible to investigate gene-diet interactions in human obesity using either 
intervention or epidemiological observational studies. The objective is to address the 
influence of each environmental factor in regard to the whole genome or specific gene 
variants influence.  
Four methods can be used to provide evidence for G x E effects in humans when 
molecular markers are available [2, 9]. The first is to compare the influence of a gene on 
a given phenotype between populations of different ethnic and cultural backgrounds. 
The second method consists of comparing the effect of a gene between subgroups of 
individuals within the same population, but categorised on the basis of variables that 
can potentially affect the phenotype under study. In the third method, the response to an 
environmental stimulus is investigated among individuals with different genotypes at a 
given gene or marker locus. A fourth method is based on the “variability gene”, which 
contributes to the susceptibility to changes in the environment. 
The overfeeding approach represents another type of intervention trial. Thus, Bouchard 
et al [37] performed studies in monozygotic twins after a long-term standardised 
overfeeding period (100 days). The volunteers, 12 pairs of identical male twins, were 
fed with a diet containing 1000 kcal above their baseline measured energy intake, 
composed of 50% carbohydrates, 35% fat, and 15 % protein. After the overfeeding 
period the weight gain achieved was 8.1 kg with a 67% of weight gain attributable to fat 
mass. Interestingly, the within-pair resemblance for changes in body weight and fat 
mass and other adiposity markers was statistically significant. To dissect the molecular 
bases of such genotype-overfeeding interaction, 40 candidate gene variants were studied 
[38]. The major association between body weight gain or subcutaneous fat mass and 
overfeeding was seen for the Gln27Glu polymorphism of the ADRB2. Surprisingly, 
non-carriers of the Glu allele were heavier (7 % increase of body weight) and had 
higher subcutaneous fat gain than Glu carriers [38].  
The literature regarding gene and diet interactions for disease risk profile is still poor. 
The most intensively studied loci are those related to cardiovascular disease risk such as 
lipase and apolipoproteins gene variants [40-42]. The polymorphisms in these genes 
 12
determined plasma lipid responses to dietary intake. Other gene variants like those 
corresponding to cholesterol ester transfer protein (CETP) and fatty-acid binding 
protein- 2 (FABP2) are starting to show indications of significant effects towards 
disease risk [43]. Specifically, the Ala54 Thr FABP2 variant appears to be associated 
with insulin sensitivity, only in individuals consuming a high-fat diet. A recent paper 
reported that postpandrial lipemia (higher chylomicron cholesterol after olive oil only)in 
subjects with the Thr 54 variant of the FABP2 is dependent on the type of fat ingested 
[44].  
Few attempts were conducted to examine the influence of gene-diet interactions on 
obesity-related phenotypes. Using case-control designs, Nieters et al [45] showed that 
allelic variants of leptin and tumor necrosis factor α (TNFα) may affect obesity risk 
depending on the levels of intake of n-6 fatty acids. While, Martinez et al [36] found a 
significant interaction between obesity risk and high levels of carbohydrates 
consumption (above 49 % of total energy) for subjects carriers of the Glu allele of the 
ADRB2. Interestingly, a set of research papers have been devoted to the interplay of the 
polymorphism Pro12 Ala of the PPARG2 gene and dietary patterns in regard to obesity 
phenotypes (Table 1). In vivo ligands for PPARG2 are thought to include a variety of 
fatty acids according to their chain length or degree of saturation. Luan et al [46] 
reported an inverse interaction between dietary polyunsaturated fat to saturated fat ratio 
(P:S ratio) with BMI among 12 Ala carriers. The mean BMI in Ala carriers is greater 
than in Pro/Pro homozygotes when P:S ratio is low. Memisoglu et al [47] in a larger-
size women population indicated the presence of associations between intake of total fat 
and BMI in regard to PPARG2 genotypes. They observed a significant trend between 
total fat intake and BMI, but only in Pro/Pro individuals [47]. However, intake of 
saturated fat was directly associated to increased BMI in carriers and non-carrier of the 
12Ala variant, and intake of monounsaturated fat was inversely associated with BMI 
only in 12 Ala carriers of the PPARG2 polymorphism [48].  
In a case-control design, Nieters at al [45] observed a higher risk of obesity for carriers 
of the Ala 12 variant with increasing intake of arachidonic acid, whereas Marti et al [36] 
reported an increased obesity risk for carriers of the 12 Ala allele when consuming more 
than 49% of total energy from carbohydrates. 
Other approach to demonstrate the mutual interactions between the genetic background 
and dietary patterns have consisted in the nutritional intervention on obese subjects 
designed to lose weight, whose outcome have been dependent on the occurrence of 
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some polymorphism in candidate gene. Positive evidences of this interplay have been 
obtained for the Trp64Arg polymorphism affecting the β3 adrenergic receptor gene [49, 
50] and for other gene polymorphisms such as those concerning the serotonin receptor 
[51], PPARγ2 [48, 52], leptin receptor [53], UCPs [54], in which the weight reduction 
was influenced by the genetic make up [55, 56]. 
  
Summary 
 
Obesity is a major chronic disease of multifactorial origin, which is dependent of 
modifiable (lifestyle) and uncontrollable risk factors (genes, age, family history, etc) 
affecting the phenotype outcome [57, 58]. Considerable research now indicates that 
genetics is a factor in determining the individuals risk to obesity and at least 430 genes 
or chromosomal markers have been identified to be putatively involved in body weight 
regulation [2]. Furthermore, diet and genetics interact in numerous ways and 
mechanisms to influence obesity onset (appetite, energy expenditure, adipogenesis, etc). 
Indeed, genetics influences the human body’s physiological response, while diet 
influences the expression of genes related to energy homeostasis [57]. 
The discrepancy among studies may reflect the difficulty of accurate measurements of 
specific types of dietary macro and micronutrients as well on the phenotype assessment 
rather than a discrepancy with biological relevance. Moreover, the different 
observations suggest that at least dietary counselling may need to be taken into 
consideration concerning the PPARG2 genotype. Identification of individuals who are 
genetically more likely to respond to particular dietary changes may be important for 
successful intervention in obesity treatment, since gene screening will allow health 
professionals to tailor-design and selective dietary counselling in individuals with 
genetic predisposition to be obese [59]. 
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TABLE 1: Summary of positive findings regarding interactions between the polymorphism Pro12Ala of the PPARG2 and dietary intake on 
obesity phenotypes.  
 
 
STUDY   POPULATION  PREVALENCE   INTERACTION BETWEEN 
    Total (Male/Women)  (% Ala homozygous) 
 
Luan  et al 2001  592 (259/333)    2%  Low PUFA to saturated fat ratio (0,55) with increased BMI  
    Non diabetic Caucasian.      (p=0.0038) 
    (age 54) 
 
Memisoglu et al 2003 2,141 Women    1.6%  Low monounsaturated fatty acid intake with increased BMI  
    BMI: 26       (low vs. high percentile) (p= 0.006) 
    (age 55)        
 
Nieters et al 2002  308 (154/154)    1.9%  High arachidonic acid intake for increased obesity risk 
    Age-sex-matched       (p=0.062) 
    C: BMI<25  O: BMI>35 
 
Marti et al 2002  313 (66/247)    0.6%  High carbohydrate intake (>49% E) for increased obesity risk  
    C: BMI<25  O: BMI>30       (p<0.04) 
    (age 41)   
______________________________________________________________________________________________________________ 
 
Figure 1. Different approaches to identify gene x nutrient interaction based on the 
assessment of the obesity risk (OR) or a phenotype marker (BMI). 
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Figure 2. A working model for the interaction of genetic and environmental factors 
involving a higher obesity risk (represented by a quantitative trait BMI) as affected by the 
dietary intake (high consumption of carbohydrates) in a population carrying a given 
polymorphism (PPAR). 
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